Hydroxypropyl-beta-cyclodextrin (HP-BCD) inhibits SARS-CoV-2 replication and virus-induced inflammatory cytokines

COVID-19 is marked by extensive damage to the respiratory system, often accompanied by systemic manifestations, due to both viral cytopathic effects and hyperinflammatory syndrome. Therefore, the development of new therapeutic strategies or drug repurposing aiming to control virus replication and in...

Descripción completa

Detalles Bibliográficos
Autores principales: Bezerra, Bruno Braz, Silva, Gustavo Peixoto Duarte da, Coelho, Sharton Vinicius Antunes, Correa, Isadora Alonso, Souza, Marcos Romario Matos de, Macedo, Keylla Vitória Gomes, Matos, Bruna Machado, Tanuri, Amilcar, Matassoli, Flavio Lemos, Costa, Luciana Jesus da, Hildreth, James E.K., Arruda, Luciana Barros de
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250893/
https://www.ncbi.nlm.nih.gov/pubmed/35798224
http://dx.doi.org/10.1016/j.antiviral.2022.105373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250893/
https://www.ncbi.nlm.nih.gov/pubmed/35798224
http://dx.doi.org/10.1016/j.antiviral.2022.105373

Ejemplares similares